COVID-19

Clinical support for low-cost tablets to treat coronavirus

Clinical support for low-cost tablets to treat coronavirus

By Nicola Gordon-Seymour

Chewable tablets or capsules formulated with dextrose or sorbitol and added bovine lactoferrin (bFL) offer a low cost and easy to produce preventative or clinical treatment for coronavirus strains, including COVID-19, according to a new study.

Getty Images / Phichaklim1

Hemp compounds block COVID-19, study finds

By Danielle Masterson

Researchers found that a pair of cannabinoid acids bind to the SARS-CoV-2 spike protein, preventing a critical step in the process the virus uses to infect people.

Getty | metamorworks

Big opportunities in merging nutra and pharma

By Nikki Hancocks

Consumer trends, technological advancements and business strategies are causing the pharma and nutra markets to merge and this opens opportunities for the players in both industries to cater to consumers looking for the ultimate wellness solutions.

Getty Images / marilyna

Must-have ingredients to include in your spring 2022 products

By Danielle Masterson

Our everyday habits and behaviors have dramatically shifted in the past two years and they continue to do so—including our dietary supplements routine. So what trends will be left in 2021 and what will roll over into 2022?

getty | sergey tinyakov

Mintel: How to make it in the mindful market

By Nikki Hancocks

Tapping into the rising consumer interest in mental health is about so much more than adding some magnesium to the mix so brands that want to win in this space will need to offer a value proposition through much more than just their products.

getty | aliseenko

UK vit D sufficiency threshold set too low, say experts

By Nikki Hancocks

The UK's current threshold for vitamin D sufficiency (25 nmol/L 25(OH)D) is not supported by evidence and a higher threshold of 50 nmol/L, achievable by supplementation with at least 800 IU per day should be urgently promoted, according to a new...

Follow us

Products

View more

Webinars